• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Sandoz in Africa - a global leader
 

Sandoz in Africa - a global leader

on

  • 448 views

Presentation by Sandoz made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

Presentation by Sandoz made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

Statistics

Views

Total Views
448
Views on SlideShare
395
Embed Views
53

Actions

Likes
0
Downloads
10
Comments
0

1 Embed 53

http://www.pharmaafrica.com 53

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Sandoz in Africa - a global leader Sandoz in Africa - a global leader Presentation Transcript

    • Sandoz - A Global Leader Nick Haggar March 2013 Head Sandoz Africa, Middle East and Western Europe
    • Sandoz a Global Leader This is the first dummy chapter 2 | Together Growing Faster - Sandoz and Celesio | October 10 th, 2012
    • Sandoz is a Novartis Group Company Environment Patient needs Novartis portfolio Innovative medicines 2011 sales USD billion Pharmaceuticals 32.5 Eye Care (Alcon, CIBA VISION) 10.0 Sandoz – Generics 9.5 Self-care Consumer Health (OTC, Animal Health) 4.6 Prevention Vaccines and Diagnostics 2.0 Affordable options Full range of healthcare options
    • Novartis’ mission is to care for and cure patients In 2011, Novartis treated and protected more than 1 billion patients around the world with our products and Sandoz medicines reached over 400 million patients
    • Sandoz is a global leader in generics 2011 generics sales1 USD million 10,196 9,473 5,559 3,320 2,432 2,358  Present in 140 countries  ~25,000 employees worldwide  Portfolio of ~1,100 compounds and >23,500 SKUs 2,313  Rich pipeline with >800 projects 2,273  Leader in differentiated generics 2,126  Biosimilars pioneer 1,876 Pro forma by including all acquired companies Note: Figures reflect sales and ROS for generics business only, including API and excluding originator (e.g. Copaxone) and proprietary business (e.g. Women’s Health) Note: All trademarks, logos and pictures are the property of the respective owner Source: Company annual and quarterly reports, except Actavis figures estimated based on IMS 1
    • Sandoz operates in 140 countries globally Development* Production* Unterach Holzkirchen Barleben Rudolstadt Subsidiaries Representative offices Boucherville Strykow Wilson Kundl / Schaftenau Ljubljana / Mengeš Broomfield Candelaria Kaminoyama Cambe/ Taboao Zhongshan Buenos Aires Gebze * Sample Sandoz manufacturing and development sites. Spartan Turbhe Kalwe Jakarta
    • Sandoz has an industry-leading breadth of technologies Biosimilars Lyophilization Ophthalmics Patches/ transdermals/ thin films Hormones Injectables Inhalers Cytotoxics API Innovative solid formulations Implants Dermatology
    • Anti-Infectives: Sandoz is the leading Gx player Total anti-infectives sales USD bn (FY 2011) Pfizer 3.7 CAGR1 Percent (200911) -6% GlaxoSmithKline 1.7 -4% Sandoz 1.7 +4% Sanofi 2 1.3 -5% Teva 1.3 -8% Merck & Co. 1.2 -12% Johnson & Johnson 1.0 -25% Daiichi Sankyo 2 0.9 -5% Medicis 0.8 +22% Bayer 0.7 -2% 1 2 Growth rate at constant currency rate Incl. Generic business Source: IMS, global market, anti-infectives defined as J1 (antibacterials) Gx Originator
    • Sandoz in first dummy chapter This is the Africa
    • Commitment and Growth in Africa World Economic Forum, Addis Ababa Wide range of bilateral meetings •4 Ministers •7 NGOs (Bill & Melinda Gates Foundation, Director-General of Red Cross, ...) •Private companies (Philips, Coca Cola, Merck, ...) •Development organizations (GIZ, US African Development Foundation, ...) Minister of Industry and Trade, Egypt Minister of Health, Ethiopia AU-UNIDO Conference on Diversified Economy and Manufacturing, Addis Ababa of bilateral meetings Wide range •Local manufacturers from Ethiopia, Kenya, Botswana, Sierra Leone, ... •UN, WHO, GIZ, British Embassy, German Embassy, Swiss Embassy
    • 5 joint projects to improve patient’s life Zambia Example Health shops Cardiovascular Academy Build high quality, affordable portfolio Rheumatic Heart Disease Zambora Project
    • Focus Areas Quality Regulatory Distribution Affordability Partnerships
    • REGIONAL FOCUS: GROWTH OPPORTUNITIES FOR PHARMA COMPANIES IN THE WEST AFRICAN MARKET DR YAW ADU GYAMFI, CEO, DANADAMS PHARMACEUTICAL INDUSTRIES NICK HAGGAR, HEAD, WESTERN EUROPE, MIDDLE EAST & AFRICA, SANDOZ MODERATOR: DR VINCE S. THOMAS, MANAGING DIRECTOR, V.S THOMAS GLOBAL HEALTH STRATEGY CONSULTING